Physiological response to superantigen-adsorbing hemoperf usion in toxin-concentration-controlled septic swine

Blood Purification

Volumn 24, Issue 3, 2006, Pages 319-326

  Miwa, Keishi ^a   Fukuyama, Mayumi ^a   Matsuno, Naoto ^b   Shimada, Kaoru ^a   Ikeda, Kazumi ^b   Ikeda, Toshiaki ^b  

^a TORAY INDUSTRIES INC   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Animal model, swine; Multiple organ dysfunctions; Sepsis; Superantigen

Indexed keywords

SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVICE; HEMADSORPTION; HEMOPERFUSION; LETHALITY; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPSIS; SUPERANTIGEN ADSORBING DEVICE; SWINE;

ADSORPTION; ANIMALS; BACTERIAL TOXINS; CARDIOVASCULAR DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; ENTEROTOXINS; HEMOPERFUSION; MALE; RESPIRATION DISORDERS; SEPSIS; SUPERANTIGENS; SURVIVAL RATE; SWINE; TIME FACTORS;

EID: 33744480780     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091851     Document Type: Article

References (19)

1. Sriskandan S, Cohen J: Gram-positive sepsis: mechanisms and differences from gram-negative sepsis. Infect Dis Clin N Am 1999;13:397-412.
2. Opal SM, Cohen J: Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 1999;27:1608-1616.
3. Cohen J: Mechanisms of tissue injury in sepsis: contrasts between gram positive and gram negative infection. J Chemother 2001; 1:153-158.
4. Llewelyn M, Cohen J: Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002:2:156-162.
5. Proft T, Fraser JD: Bacterial Superantigens. Clin Exp Immunol 2003; 133:299-306.
6. Miwa K, Fukuyama M, Kunitomo T, Igarashi H: Rapid assay for detection of toxic shock syndrome toxin 1 from human sera. J Clin Microbiol 1994:32:539-542.
7. Sriskandan S, Moyes D, Cohen J: Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome. Lancet 1996:348:1315-1316.
8. de Azavedo JC: Animal models for toxic shock syndrome: overview. Rev Infect Dis 1989;11: S205-S209.
9. Azuma K, Koike K, Kobayashi T, Mochizuki T, Mashiko K, Yamamoto Y: Detection of circulating superantigens in an intensive care unit population. Int J Infect Dis 2004:8:292-298.
10. Miwa K, Fukuyama M, Ida N, Igarashi H, Uchiyama T: Preparation of superantigen-adsorbing device and its superantigen removal efficacies in vitro and in vivo. Int J Infect Dis 2003:7:21-28.
11. Nagaki M, Hughes RD, Keane HM, Goka J, Williams R: Clearance and tissue distribution of staphylococcal enterotoxin A in the rat potential use of adsorbents for removal from plasma. J Med Microbiol 1993:38:354-359.
12. Fenwick P, Ryan C, Sriskandan S, Cohen J: Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med 2003;31:171-178.
13. Fukuyama M, Miwa K, Shibayama N, Ogura S, Nishiyama T, Maekawa N: Mixed bacterial infection model of sepsis in rabbits and efficacy evaluation of superantigen-adsorption device. Blood Purif 2005;23:119-127.
14. Miwa K, Fukuyama M, Matsuno N, Masuda S, Ikeda K, Ikeda T: Superantigen induced multiple organ dysfunction in a toxin-concentration controlled and sequential parameter monitored swine sepsis model. Int J Infect Dis, in press.
15. Igarashi H, Fujikawa H, Usami H, Kawabata S, Morita T: Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins. Infect Immun 1984;44:175-181.
16. Bernard GR, Artigas A, Brigham KL, et al: Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intens Care Med 1994;20:225-232.
17. Holtfreter S, Bröker BM: Staphylococcal superantigens: do they play a role in sepsis? 2005;53:13-27.
18. Igarashi H, Fujikawa H, Usami H: Effect of drug on the pyrogenicity of toxic shock syndrome toxin-1 and its capacity to enhance susceptibility to the lethal effect of endotoxin shock in rabbis. Rev Infect Dis 1989;2:S210-S213.
19. Blank C, Luz A, Bendigs S, Erdmann A, Wagner H, Heeg K: Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol 1997:27:825-833.